|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.36 USD | -2.60% |
|
-4.47% | +13.85% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 29.58B | |||||
| 67.44B | |||||
| 53.98B | |||||
| 41.77B | |||||
| 41.15B | - | ||||
| 29.28B | - |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
